NCT07091396 2026-01-30
Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery
Mayo Clinic
Phase NA Enrolling by invitation
Clinical Trials
17 trialsNCT07085494 2026-01-27
Neurofeedback and Cognitive Training for PBTS
The University of Hong Kong
Phase NA Enrolling by invitation
NCT06763965 2025-12-02
A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2 Enrolling by invitation
NCT06300502 2025-11-20
Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)
Massachusetts General Hospital
Phase 1 Enrolling by invitation
NCT07126990 2025-09-23
Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2 Enrolling by invitation
NCT05014841 2025-09-16
The Neural Coding of Speech Across Human Languages
University of California, San Francisco
Phase NA Enrolling by invitation
NCT02670161 2025-08-24
Quality Improvement and Practice Based Research in Neurology Using the EMR
Endeavor Health
Phase 4 Enrolling by invitation
NCT07130149 2025-08-19
Sonodynamic-Chemoradiotherapy Integration in Glioblastoma
The First Affiliated Hospital of Zhengzhou University
Phase 2 Enrolling by invitation
NCT06896110 2025-06-26
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
University of Iowa
Phase 1 Enrolling by invitation
NCT05435859 2025-06-08
Functional Organization of the Superior Temporal Gyrus for Speech Perception
University of California, San Francisco
Phase NA Enrolling by invitation
NCT06999148 2025-05-31
Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis
The First Affiliated Hospital of Zhengzhou University
Phase 2 Enrolling by invitation
NCT06690216 2025-03-30
PD-L1-PET
Shandong Cancer Hospital and Institute
Phase 1/2 Enrolling by invitation
NCT01868490 2025-02-10
The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells
Siriraj Hospital
Phase 1/2 Enrolling by invitation
NCT03170141 2025-01-20
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
Shenzhen Geno-Immune Medical Institute
Phase 1 Enrolling by invitation
NCT06753617 2024-12-31
Cryoablation of Brain Neoplasm
Erasmus Medical Center
Phase NA Enrolling by invitation
NCT06616727 2024-09-27
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
Shanghai Simnova Biotechnology Co.,Ltd.
Phase 1 Enrolling by invitation
NCT05116137 2024-03-12
RESIST
Nova Scotia Health Authority
Phase NA Enrolling by invitation